Plegridy (Peginterferon beta 1a)

Brand Options

arrow pointer

Brand Name : Plegridy

Marketing Authorization Holder : Biogen Idec

Prescription Required

Temp Controlled Express Courier

No Generic Medicine available for this medicine.

Product Details


Prescription Plegridy contains the active ingredient peginterferon beta-1a. Pegridy is used by adults with relapsing/remitting multiple sclerosis. Plegridy is a modified version of long acting interferon which helps the body protect itself against infections and diseases.

Multiple sclerosis is an illness that affects the brain and spinal cord where the body's immune system attacks the myelin which surround and protects the nerves located there. By disrupting the nerves, multiple sclerosis disrupts messages between the brain and the body, causing the symptoms associated with the disease. Plegridy is not a cure, but it stops the damage by your own immune system reducing the number of relapses thus slowing down the effects of multiple sclerosis.

The standard Plegridy dose is 125 mcg every 2 weeks at the same day every 14 days. When you begin with Plegridy, the dose may be less than 125 mcg. Each package of Plegridy contains 2 prefilled pens which is a 4 week supply. Plegridy is the only interferon used every 2 weeks.

Before injecting yourself with Plegridy, have your physician train you exactly how to use the pen. Be fully comfortable before you self-inject Plegridy. Follow the directions contained in the box and inject Plegridy under the skin using alternate sites for injection.

In 2019, when comparing Plegridy cost to USA Plegridy coupon price, InsulinHub was found to offer a discount of approximately 55% in Plegridy savings. 

Buy Plegridy from for the best Plegridy cost.

This product requires special packaging to maintain its integrity during the shipping process. DO NOT USE THIS MEDICATION if the attached temperature indicator shows that the medication was exposed to temperatures below 2 degrees or above 8 degrees celsius, and contact the pharmacy immediately.

Image Image Image Image